|
|
Untreated (non-apoptotic) MCF-7 cells imaged under white light
|
Untreated MCF-7 cells imaged using fluorescence (DAPI)
|
|
Untreated cells
|
All cells
|
|
|
|
Further information
|
Untreated (non-apoptotic) HeLa cells
|
Treated (apoptotic) HeLa cells showing condensed, fragmented chromatin
|
|
Non-apoptotic cell with decondensed, non-fragmented nucleus
Apoptotic cell with condensed, fragmented nucleus
|
Further information
Cytotoxic response - determine 'dead-cell' population
|
Diameter of pie chart = cell number
Slices in pie chart = live:dead cells |
Dose response curve from exported data
|
|
|
Further information
|
Diameter of pie chart = cell number
Slices in pie chart = viable:non-viable cells |
Dose response curve from exported data
|
|
|
Further information
|
Histogram: distribution of Cy3 interior mean fluorescence: Cy3 exterior mean fluorescence. |
Fixed HeLa cells. Analysis within histogram is represented in the images.
|
|
|
Further information
|
Fluorescent imaging
|
Nuclei identified
|
|
Histogram: distribution of total nuclear intensities in Texas Red channel |
Analysis within histogram represented in images |
|
G2 cells (4n DNA, de-condensed nuclei) distinguished from pre-anaphase mitotic cells (4n DNA, condensed nuclei)
|
Post-metaphase mitotic cells (2n DNA, condensed nuclei) distinguished from G1 cells (2n DNA, de-condensed nuclei)
|
|
Changes in nuclear DNA throughout the cell cycle
|
Further information
|
Plate Overview illustrates a heat map representation of the distribution of fluorescent bead intensity per well across the plate
|
|
Standard curve shows comparable results between the homogeneous bead assay and an ELISA approach
|
|
|
Further information
Phenotypic Screening to Identify Cures for the Deadliest Poison
Dr. Tobin Dickerson, The Scripps Research Institute, San Diego, CA
Accelerated high content screening and homogeneous quantification of soluble IgG levels
Dr Alasdair Robertson, Head of Biology R&D, Genetix Limited
Dr Robertson demonstrates how utilizing the CellReporter™ system's quantitative approach to assessing IgG levels can save time and simplify workflow compared to conventional methods such as FMAT®.